Guide to Analytical Testing
In this guide to Analytical Testing, SUEZ explains how to maximise efficiency without compromising on quality.
List view / Grid view
Articles
Using plants as bioreactors to produce proteins for therapeutics
European Pharmaceutical Review explores how plants can be used for large-scale, glycosylated protein bioproduction for the pharma industry.
Challenges in today’s pharmaceutical formulation
Dr Finn Bauer discusses how Merck KGaA and its SAFC® portfolio brand is addressing drug formulator challenges.
Under the microscope: Mitigating risks in manufacturing processes
In the light of recent media coverage about product recalls – particularly resulting from the detection and presence of NDMA – this article outlines ways to avoid the wide-ranging negative impacts on patients, pharmacies, manufacturers, pharmaceutical companies and health authorities and offers ways to mitigate the risk of future recalls.
QA/QC & Analytical Techniques In-Depth Focus 2020
Within this in-depth focus are articles on how the regulation of heavy metals in cannabis can benefit from lessons learned in pharma and the advantages of using electron paramagnetic resonance (EPR) as an imaging technique.
Manufacturing, Packaging & Logistics In-Depth Focus 2020
In this in-depth focus are articles discussing how to optimise production by using the correct tablet tooling and why logistics can be affected by developments in the pharmaceutical industry.
Formulation, Development & Delivery In-Depth Focus 2020
Included in this in-depth focus is an analysis of the benefits of using polyelectrolyte multilayers as therapeutic agent carriers and a comparison of various methods to characterise the flowability of powder blends.
European Pharmaceutical Review Issue 1 2020
Within this issue are articles which investigate polyelectrolyte multilayers as drug carriers, discuss how developments in pharma impact logistics and examine how the industry can regulate heavy metals in medicinal cannabis. Other features include how to use the correct tablet tooling and trends for the CDMO sector this year.
The importance of labelling compliance for pharma
Bart Vansteenkiste explains why it is important to validate pharmaceutical labelling compliance to ensure good manufacturing practice.
Treating multi-drug resistant Mycobacterium abscessus: three’s a charm
Researchers at Aston University and Birmingham Children’s Hospital, UK, have discovered a highly effective three-drug approach to treat Mycobacterium abscessus (M. abscessus), a notoriously drug-resistant pathogen that affects up to 13 percent of cystic fibrosis (CF) patients in the UK.
Resolving and mitigating medicine shortages in the EU
Drug shortages can greatly impact patients and the pharmaceutical industry. Adrian van den Hoven, Director General of Medicines for Europe, explains how to prevent and reduce the effects of medicinal scarcities in the EU.
Does the antibacterial pipeline sufficiently target WHO priority pathogens?
A WHO review has concluded that while innovative therapies have been developed for TB and C. diff, other priority pathogens are likely to develop resistance to future therapies.
Medical Devices Regulation: delays and confusion
The EU Medical Devices Regulation will apply in May 2020. Maurits Lugard and Josefine Sommer of Sidley Austin LLP examine what the changes mean for the medtech industry.
Five of the most recent pharma collaborations in 2020
As companies continue to collaborate and share their expertise to develop therapeutics targeting a wide range of diseases, European Pharmaceutical Review explores the aims of the most recent partnerships.
Spotlight: a dispersible tablet formulation to treat HIV in children
A novel formulation for dolutegravir has been developed to improve HIV treatment options for children. Dr Kimberly Smith from ViiV Healthcare discusses the benefits of this new dispersible tablet.
